Comment on CMS-2026-1255-0001

Summary: The Association of American Medical Colleges (AAMC) supports the proposed rule to streamline and standardize prior authorization processes, specifically praising the alignment of decision timelines and the requirement for specific denial reasons. They also advocate for stricter timelines for prescription drugs, restrictions on prior authorization for substance use disorder treatment, and a consensus-driven, risk-based approach to cybersecurity requirements.